ATE449088T1 - Thiazolinsäure-derivate - Google Patents

Thiazolinsäure-derivate

Info

Publication number
ATE449088T1
ATE449088T1 AT03021526T AT03021526T ATE449088T1 AT E449088 T1 ATE449088 T1 AT E449088T1 AT 03021526 T AT03021526 T AT 03021526T AT 03021526 T AT03021526 T AT 03021526T AT E449088 T1 ATE449088 T1 AT E449088T1
Authority
AT
Austria
Prior art keywords
acid derivatives
thiazolic
thiazolic acid
derivatives
thiazoline
Prior art date
Application number
AT03021526T
Other languages
English (en)
Inventor
Raymond J Bergeron Jr
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Application granted granted Critical
Publication of ATE449088T1 publication Critical patent/ATE449088T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/10—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT03021526T 1996-03-29 1997-03-31 Thiazolinsäure-derivate ATE449088T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/624,289 US5840739A (en) 1992-11-16 1996-03-29 Thiazoline acid derivatives

Publications (1)

Publication Number Publication Date
ATE449088T1 true ATE449088T1 (de) 2009-12-15

Family

ID=24501405

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03021526T ATE449088T1 (de) 1996-03-29 1997-03-31 Thiazolinsäure-derivate

Country Status (13)

Country Link
US (1) US5840739A (de)
EP (3) EP0900209A4 (de)
JP (2) JP3800559B2 (de)
KR (1) KR20000005100A (de)
AT (1) ATE449088T1 (de)
AU (1) AU715889B2 (de)
BR (1) BR9708460A (de)
CA (1) CA2250243C (de)
DE (1) DE69739670D1 (de)
NO (1) NO315608B1 (de)
NZ (2) NZ509967A (de)
PL (1) PL329172A1 (de)
WO (1) WO1997036885A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045531B1 (en) 1997-03-11 2006-05-16 The General Hospital Corporation Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelator
ES2235461T3 (es) * 1998-02-04 2005-07-01 University Of Florida Research Foundation, Inc. Acido n,n'-bis (2-hidroxibencil)etilendiamina-n,n'-diacetico y sales de sodio de este para terapia quelante de hierro.
US6638711B1 (en) 1999-04-29 2003-10-28 The General Hospital Corporation Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation
US6323218B1 (en) 1998-03-11 2001-11-27 The General Hospital Corporation Agents for use in the treatment of Alzheimer's disease
US6083966A (en) * 1998-08-31 2000-07-04 University Of Florida Thiazoline acid derivatives
US6159983A (en) * 1998-09-18 2000-12-12 University Of Florida Method and composition for treatment of inflammatory bowel disease
EP1488791A3 (de) * 1998-09-21 2005-04-06 University Of Florida Research Foundation, Inc. Mittel gegen malaria
NZ509172A (en) * 1998-09-21 2004-02-27 Univ Florida Antimalarial agents
CA2394524A1 (en) 1999-12-21 2001-06-28 Raymond J. Bergeron N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid in iron chelating therapy
US6689788B1 (en) * 2000-08-25 2004-02-10 University Of Florida Method and composition for treatment of inflammatory bowel disease
US6794515B2 (en) * 2002-05-15 2004-09-21 Genzyme Corporation Synthesis of 2-alkylcysteine via substituted thiazoline amide
US20040044220A1 (en) * 2002-08-22 2004-03-04 University Of Florida Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
AU2003263948A1 (en) * 2002-08-22 2004-03-11 University Of Florida Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
CA2497560A1 (en) 2002-09-20 2004-04-01 Promega Corporation Luminescence-based methods and probes for measuring cytochrome p450 activity
AU2003270473A1 (en) * 2003-09-09 2005-04-27 University Of Florida Desferrithiocin derivatives and their use as iron chelators
JP5202299B2 (ja) 2005-04-04 2013-06-05 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイティド デフェリチオシンポリエーテル類似体
EP1885875B1 (de) 2005-05-31 2019-05-22 Promega Corporation Luminogene und fluorogene verbindungen und verfahren für den nachweis von molekülen oder leiden
AU2008229472B2 (en) 2007-03-15 2013-03-14 University Of Florida Research Foundation, Inc. Desferrithiocin polyether analogues
JP5597200B2 (ja) 2008-08-18 2014-10-01 プロメガ コーポレイション ルミネッセンスを生じる化合物およびチトクロムｐ４５０３ａ酵素を検出するための方法
EP2459544A4 (de) * 2009-07-27 2012-12-05 Ferrokin Biosciences Inc Prodrugs aus desazadesferrothiocin-polyether-analogen als metallchelierungsmittel
WO2013090750A1 (en) 2011-12-16 2013-06-20 University Of Florida Research Foundation, Inc. Uses of 4'-desferrithiocin analogs
JP6838966B2 (ja) 2013-11-22 2021-03-03 ユニバーシティー オブ フロリダ リサーチ ファンデーション， インク． デスフェリチオシン類似体およびその使用
EP3099683B1 (de) 2014-01-29 2020-08-05 Promega Corporation Chinonmaskierte sonden als markierungsreagenzien für zellaufnahmemessungen
AU2016255770A1 (en) 2015-04-27 2017-11-16 University Of Florida Research Foundation, Incorporated Metabolically programmed metal chelators and uses thereof
KR20210015892A (ko) 2018-05-29 2021-02-10 세르시 테라퓨틱스 인코포레이티드 통증 치료를 위한 화합물, 이를 포함하는 조성물 및 이를 사용하는 방법
MX2021013524A (es) 2019-05-10 2021-12-10 Cersci Therapeutics Inc Metodos de fabricacion y polimorfos de un agente antihiperalgesico de tiazolina.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1137529A (en) * 1967-05-04 1968-12-27 Wyeth John & Brother Ltd Thiazole compositions
CY800A (en) * 1968-04-09 1976-12-01 Wyeth John & Brother Ltd Novel thiazoline derivatives, the preparation thereof and compositions containing the same
DE3002989A1 (de) * 1980-01-29 1981-07-30 Hoechst Ag, 6000 Frankfurt Hydroxyphenyl-thiazol, -thiazolin und -thiazolidin-carbonsaeuren, verfahren zu ihrer herstellung und ihre verwendung zur beeinflussung des kollagenstoffwechsels
EP0045281B1 (de) * 1980-07-28 1985-05-08 Ciba-Geigy Ag Thiazolinderivate und Verfahren zu ihrer Herstellung
US5393777A (en) * 1990-11-15 1995-02-28 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon Health Sciences University Deferration using anguibactin siderophore
WO1994011367A1 (en) * 1992-11-16 1994-05-26 University Of Florida Research Foundation Inc. 2-(pyrid-2'-yl)-2-thiazoline-4(s)-carboxylic acid derivatives

Also Published As

Publication number Publication date
CA2250243A1 (en) 1997-10-09
EP2096112A3 (de) 2009-09-09
AU2541097A (en) 1997-10-22
DE69739670D1 (de) 2009-12-31
JP2000505086A (ja) 2000-04-25
JP2006152004A (ja) 2006-06-15
NO984508L (no) 1998-11-23
KR20000005100A (ko) 2000-01-25
PL329172A1 (en) 1999-03-15
EP0900209A1 (de) 1999-03-10
EP0900209A4 (de) 2001-09-19
NO984508D0 (no) 1998-09-28
WO1997036885A1 (en) 1997-10-09
NZ509967A (en) 2005-06-24
AU715889B2 (en) 2000-02-10
NZ332049A (en) 2001-04-27
BR9708460A (pt) 2000-01-04
EP1380577A1 (de) 2004-01-14
EP2096112A2 (de) 2009-09-02
JP3800559B2 (ja) 2006-07-26
US5840739A (en) 1998-11-24
NO315608B1 (no) 2003-09-29
CA2250243C (en) 2002-10-08
EP1380577B1 (de) 2009-11-18

Similar Documents

Publication Publication Date Title
ATE449088T1 (de) Thiazolinsäure-derivate
NO940789D0 (no) Quinolinkarboksylsyrederivater, deres fremstilling og anvendelse
ATE196761T1 (de) Inhibitoren retroviraler proteasen
DK0788360T3 (da) Boronsyreester- og syreforbindelser, deres syntese og anvendelser
DE3867572D1 (de) Benzothiazol-derivat und es als aktiven bestandteil enthaltendes antirheumatisches mittel.
DE69316717D1 (de) Inhibitoren mit zweifacher Wirkung
GB9801690D0 (en) Therapeutic agents
FI942423A7 (fi) Sakkariinijohdannisia proteolyyttisen entsyymin inhibiittoreina
ES2179587T3 (es) Utilizacion de betainas como agentes antitranspirantes.
DE69329996D1 (de) Inhibitoren retroviraler proteasen
ATE131154T1 (de) Phenylalkan(en)säuren.
NO903640D0 (no) Fremgangsmaate for fremstilling av 2-(rs)-substituerte 2,3-dihydro-5-oksy-4,6,7-trimetylbenzofuraner.
DE69715619D1 (de) Inhibition der matrix metalloproteasen durch 2-(omega-aroylalkyl)-4-biaryl-4-oxobutansäuren
FI925544A7 (fi) Bentsoehappojohdannaisia leukotrieeniin liittyvien sairauksien hoitami seen
DK0617959T3 (da) Lægemiddel til behandling af hudsygdomme
NO892189L (no) Trijodbenzenforbindelser og kontrastmidler for radiografiinneholdende disse.
DK0490634T3 (da) Quinoliniumsaltmellemprodukter
ATE84303T1 (de) Cysteinderivate.
DE59608306D1 (de) Schaltung zur Stromversorgung mehrerer Leistungsverstärker
ATE244697T1 (de) Phenylester-derivate von alpha-aminosäuren
FI960371A7 (fi) Tiatsolijohdannaisia lipoksigenaasi-inhibiittoreina
ATE137973T1 (de) Phospholipide zur behandlung der multiplen sklerose
DE69524574D1 (de) Enzymatische spaltung von substituierter 2-methylpropionsäure
FI942397L (fi) Menetelmä 2-amino-3-hydroksihappojen valmistamiseksi
KR970050150U (ko) 마이크로 프로세서의 구동전원 공급회로

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties